-
CEPI and European Investment Bank collaborate to Fund Vaccine Projects
Europeanpharmaceuticalreview
May 07, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) and European Investment Bank (EIB) will work together to identify and fund vaccine projects for infectious diseases.
-
First Patient Dosed With Pfizer’s Potential COVID-19 Vaccine in US
europeanpharmaceuticalreview
May 07, 2020
Pfizer and BioNTech have initiated Phase I/II trials in the US to determine the safety and optimal dose of four mRNA COVID-19 vaccine candidates.
-
Open Science: Key to combat zoonosis
expresspharma
May 07, 2020
“There are decades where nothing happens, and there are weeks where decades happen.” These words by Russian revolutionary, Vladimir Lenin describes the current scenario to a ‘T’.
-
Vaxxel buys Transgene’s cell line to develop new vaccines
pharmaceutical-technology
May 05, 2020
French vaccines startup Vaxxel has acquired Transgene’s DuckCelt T17 cell line to develop industrial-scale vaccines against respiratory viruses.
-
UK vaccine clinical trial outsourcing expansion continues
europeanpharmaceuticalreview
May 05, 2020
An outsourcing company has announced that Phase II, III and IV clinical trials of vaccines will continue at a growing number of sites, assessing the safety of each in light of COVID-19.
-
Shionogi works on Covid-19 therapies and vaccine
pharmaceutical-technology
April 30, 2020
Japanese-based Shionogi has partnered with public institutions, academia and other companies to develop potential drugs and vaccine against Covid-19.
-
IIT Guwahati collaborates with Hester Biosciences to develop vaccine against COVID-19
expresspharma
April 29, 2020
The vaccine will be based on recombinant avian paramyxovirus-based vector platform, the company said.
-
Serum Institute plans to price coronavirus vaccine at ₹1,000 if trials succeed
expresspharma
April 29, 2020
The Serum Institute of India announced that it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain.
-
Valo Tx Working to Develop Potential COVID-19 Vaccine
contractpharma
April 28, 2020
Will use PeptiCRAd technology with HLA-matched peptides optimized to further boost CD8+ T-cell immune responses.
-
Plans afoot to develop COVID-19 vaccine at the earliest: Dr Harsh Vardhan
expresspharma
April 27, 2020
Serum Institute of India is collaborating with Oxford University to make the Covid-19 vaccine.